glutathione increase after treating with platinum drugs

glutathione increase after treating with platinum drugs Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Understanding and Improving Platinum Anticancer

Name: glutathione increase after treating with platinum drugs Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Understanding and Improving Platinum Anticancer
Brand: astonvaughan.co.uk
SKU: 61728050298
Price: 29.63 USD
Availability: InStock
Rating: 4.7857 (12 reviews)

Understanding and Improving Platinum Anticancer Drugs Phenanthriplatin PMC Glutathione: Lights and Shadows in Cancer Patients PMC Frontiers Glutathione responsive and exhausting metal nanomedicines for robust synergistic cancer therapy Glutathione Mediated Conjugation of Anticancer Drugs: An Overview of Reaction Mechanisms and Biological Significance for Drug Detoxification and Bioactivation PMC

SKU: 61728050298 · From astonvaughan.co.uk

4.8

USD29.63 USD72.63

Pay in 4 interest-free payments of $7.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Food Chem 2012

A significant increase in the levels of ROS and malondialdehyde in liver and kidney along with a dose-dependent increase in superoxide dismutase and catalase activities was reported

Bacterial L-forms have relatively low ROS levels because mutations reduce ROS production via the respiratory chain

The specific activities were 10.2 U/mg with DTNB, 2.2 U/mg with Trx (coupled to insulin reduction), 7.2 U/mg with GSSG, and 9.9 U/mg in a Grx assay coupled to HED